{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T17:30:22Z","timestamp":1774459822800,"version":"3.50.1"},"reference-count":24,"publisher":"e-Century Publishing Corporation","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/flyc9199","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T04:18:36Z","timestamp":1732853916000},"page":"6946-6954","source":"Crossref","is-referenced-by-count":2,"title":["Effect of low-molecular-weight heparin on gestational sac and embryo development, and miscarriage prevention for recurrent spontaneous abortion"],"prefix":"10.62347","volume":"16","author":[{"given":"Fan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref0","unstructured":"Duckitt K and Qureshi A. Recurrent miscarriage. BMJ Clin Evid 2011; 2011: 1409."},{"key":"ref1","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.fertnstert.2023.09.006","article-title":"Series of overviews on miscarriage and recurrent miscarriage","volume":"120","author":"van Wely","year":"2023","unstructured":"van Wely M. Series of overviews on miscarriage and recurrent miscarriage. Fertil Steril 2023; 120: 932-933.","journal-title":"Fertil Steril"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.fertnstert.2023.08.952","article-title":"Genetic causes of sporadic and recurrent miscarriage","volume":"120","author":"Melo","year":"2023","unstructured":"Melo P, Dhillon-Smith R, Islam MA, Devall A and Coomarasamy A. Genetic causes of sporadic and recurrent miscarriage. Fertil Steril 2023; 120: 940-944.","journal-title":"Fertil Steril"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ejogrb.2023.05.031","article-title":"Pregnancy outcomes and adverse events in patients with recurrent miscarriage receiving fondaparinux versus low molecular-weight heparin: a meta-analysis","volume":"287","author":"Mu","year":"2023","unstructured":"Mu F, Wang M, Huang J and Wang F. Pregnancy outcomes and adverse events in patients with recurrent miscarriage receiving fondaparinux versus low molecular-weight heparin: a meta-analysis. Eur J Obstet Gynecol Reprod Biol 2023; 287: 29-35.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tjog.2020.11.001","article-title":"The role of low molecular weight heparin on recurrent pregnancy loss: a systematic review and meta-analysis","volume":"60","author":"Jiang","year":"2021","unstructured":"Jiang F, Hu X, Jiang K, Pi H, He Q and Chen X. The role of low molecular weight heparin on recurrent pregnancy loss: a systematic review and meta-analysis. Taiwan J Obstet Gynecol 2021; 60: 1-8.","journal-title":"Taiwan J Obstet Gynecol"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Ni L, Sun XQ, Zhao DX and Zhu ZW. Low molecular weight heparin monotherapy for recurrent abortion with antiphospholipid system: a protocol of a systematic review. Medicine (Baltimore) 2019; 98: e14619.","DOI":"10.1097\/MD.0000000000014619"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1128362","DOI":"10.3389\/fendo.2023.1128362","article-title":"A homozygous KASH5 frameshift mutation causes diminished ovarian reserve, recurrent miscarriage, and non-obstructive azoospermia in humans","volume":"14","author":"Hou","year":"2023","unstructured":"Hou X, Zeb A, Dil S, Zhou J, Zhang H, Shi B, Muhammad Z, Khan I, Zaman Q, Shah WA, Jiang X, Wu L, Ma H and Shi Q. A homozygous KASH5 frameshift mutation causes diminished ovarian reserve, recurrent miscarriage, and non-obstructive azoospermia in humans. Front Endocrinol (Lausanne) 2023; 14: 1128362.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"769","DOI":"10.3390\/ijms21030769","article-title":"Effects of natural progesterone and synthetic progestin on germ layer gene expression in a human embryoid body model","volume":"21","author":"Kim","year":"2020","unstructured":"Kim YY, Kim H, Suh CS, Liu HC, Rosenwaks Z and Ku SY. Effects of natural progesterone and synthetic progestin on germ layer gene expression in a human embryoid body model. Int J Mol Sci 2020; 21: 769.","journal-title":"Int J Mol Sci"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Practice Committee of the American Society for Reproductive Medicine. Electronic address: asrm@asrm.org. Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril 2020; 113: 533-535.","DOI":"10.1016\/j.fertnstert.2019.11.025"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ejogrb.2021.03.001","article-title":"Low-molecular-weight heparin for prevention of unexplained recurrent miscarriage","volume":"260","author":"Scarrone","year":"2021","unstructured":"Scarrone M, Villanacci R, Canti V, Bordoli S, Pasi F, Quaranta L, Candiani M, Rovere-Querini P and Vanni VS. Low-molecular-weight heparin for prevention of unexplained recurrent miscarriage. Eur J Obstet Gynecol Reprod Biol 2021; 260: 235-236.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"10971","DOI":"10.21037\/apm-21-2605","article-title":"Efficacy of dydrogesterone on treating recurrent miscarriage and its influence on immune factors: a systematic review and meta-analysis","volume":"10","author":"Guo","year":"2021","unstructured":"Guo H and Lu Q. Efficacy of dydrogesterone on treating recurrent miscarriage and its influence on immune factors: a systematic review and meta-analysis. Ann Palliat Med 2021; 10: 10971-10985.","journal-title":"Ann Palliat Med"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"242","DOI":"10.4274\/tjod.galenos.2023.66789","article-title":"Threatened miscarriage and recurrent miscarriage: expert opinions on progesterone therapy and treatment challenges","volume":"20","author":"Demir","year":"2023","unstructured":"Demir SC, Gedikbasi A, Timur H, Cetin C, Gursoy Pala H and Gulumser C. Threatened miscarriage and recurrent miscarriage: expert opinions on progesterone therapy and treatment challenges. Turk J Obstet Gynecol 2023; 20: 242-248.","journal-title":"Turk J Obstet Gynecol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1177\/1076029616665167","article-title":"Low-molecular-weight heparin for the treatment of unexplained recurrent miscarriage with negative antiphospholipid antibodies: a randomized controlled trial","volume":"23","author":"Shaaban","year":"2017","unstructured":"Shaaban OM, Abbas AM, Zahran KM, Fathalla MM, Anan MA and Salman SA. Low-molecular-weight heparin for the treatment of unexplained recurrent miscarriage with negative antiphospholipid antibodies: a randomized controlled trial. Clin Appl Thromb Hemost 2017; 23: 567-572.","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"260","DOI":"10.5603\/GP.a2017.0049","article-title":"The impact of low molecular weight heparin on obstetric outcomes among unexplained recurrent miscarriages complicated with methylenetetrahydrofolate reductase gene polymorphism","volume":"88","author":"Cetin","year":"2017","unstructured":"Cetin O, Karaman E, Cim N, Dirik D, Sahin HG, Kara E and Esen R. The impact of low molecular weight heparin on obstetric outcomes among unexplained recurrent miscarriages complicated with methylenetetrahydrofolate reductase gene polymorphism. Ginekol Pol 2017; 88: 260-265.","journal-title":"Ginekol Pol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s10815-020-01764-z","article-title":"Evidence from three cohort studies on the expression of MUC16 around the time of implantation suggests it is an inhibitor of implantation","volume":"37","author":"Liu","year":"2020","unstructured":"Liu L, Wang Y, Chen X, Tian Y, Li TC, Zhao L, Chen Q, Wei M and Zhang S. Evidence from three cohort studies on the expression of MUC16 around the time of implantation suggests it is an inhibitor of implantation. J Assist Reprod Genet 2020; 37: 1105-1115.","journal-title":"J Assist Reprod Genet"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"4581900","DOI":"10.1155\/2021\/4581900","article-title":"Cluster-based immunotherapy for patients with recurrent abortion caused by antiphospholipid syndrome","volume":"2021","author":"Wang","year":"2021","unstructured":"Wang R, Yu J, Yan Z, Cheng X, Chen J and Guo Y. Cluster-based immunotherapy for patients with recurrent abortion caused by antiphospholipid syndrome. J Healthc Eng 2021; 2021: 4581900.","journal-title":"J Healthc Eng"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"9134","DOI":"10.3390\/ijms22179134","article-title":"Prostaglandin E2 receptor 4 (EP4) affects trophoblast functions via activating the cAMP-PKA-pCREB signaling pathway at the maternal-fetal interface in unexplained recurrent miscarriage","volume":"22","author":"Peng","year":"2021","unstructured":"Peng L, Chelariu-Raicu A, Ye Y, Ma Z, Yang H, Ishikawa-Ankerhold H, Rahmeh M, Mahner S, Jeschke U and von Schonfeldt V. Prostaglandin E2 receptor 4 (EP4) affects trophoblast functions via activating the cAMP-PKA-pCREB signaling pathway at the maternal-fetal interface in unexplained recurrent miscarriage. Int J Mol Sci 2021; 22: 9134.","journal-title":"Int J Mol Sci"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.fertnstert.2011.12.002","article-title":"Effects of low molecular weight heparin and heparin-binding epidermal growth factor on human trophoblast in first trimester","volume":"97","author":"Chen","year":"2012","unstructured":"Chen Y, Wu XX, Tan JP, Liu ML, Liu YL and Zhang JP. Effects of low molecular weight heparin and heparin-binding epidermal growth factor on human trophoblast in first trimester. Fertil Steril 2012; 97: 764-770.","journal-title":"Fertil Steril"},{"key":"ref18","unstructured":"Cang R, Hu Z, Tian Z, Xia T, Gao Y, Fu Z, He M, Ma S and Ding X. Efficacy and safety of the Bushen-Shugan method in pregnancy outcomes in patients with recurrent miscarriage complicated by anxiety and depression: a prospective randomized trial. Altern Ther Health Med 2022; 28: 124-131."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"504","DOI":"10.5603\/GP.2016.0034","article-title":"Correlation between factor VII and PAI-1 genetic variants and recurrent miscarriage","volume":"87","author":"Barlik","year":"2016","unstructured":"Barlik M, Seremak-Mrozikiewicz A, Drews K, Klejewski A, Kurzawinska G, Lowicki Z and Wolski H. Correlation between factor VII and PAI-1 genetic variants and recurrent miscarriage. Ginekol Pol 2016; 87: 504-509.","journal-title":"Ginekol Pol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"100","DOI":"10.22551\/2022.36.0903.10211","article-title":"Hypofibrinogenemia and miscarriage: report of a first successful pregnancy under fibrinogen substitution and short review of the literature","volume":"9","author":"Sucker","year":"2022","unstructured":"Sucker C, Geisen C, Schmitt U and Zawislak B. Hypofibrinogenemia and miscarriage: report of a first successful pregnancy under fibrinogen substitution and short review of the literature. Arch Clin Cases 2022; 9: 100-103.","journal-title":"Arch Clin Cases"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/humupd\/dmaa063","article-title":"First trimester mechanisms of gestational sac placental and foetal teratogenicity: a framework for birth cohort studies","volume":"27","author":"JJ","year":"2021","unstructured":"Adibi JJ, Layden AJ, Birru RL, Miragaia A, Xun X, Smith MC, Yin Q, Millenson ME, O’Connor TG, Barrett ES, Snyder NW, Peddada S and Mitchell RT. First trimester mechanisms of gestational sac placental and foetal teratogenicity: a framework for birth cohort studies. Hum Reprod Update 2021; 27: 747-770.","journal-title":"Hum Reprod Update"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.3390\/medicina58111688","article-title":"Hysteroscopic removal of intrauterine device in pregnancy: a scoping review to guide personalized care","volume":"58","author":"Stabile","year":"2022","unstructured":"Stabile G, Cracco F, Nappi L, Sorrentino F, Vitale SG, Angioni S, Carlucci S and Ricci G. Hysteroscopic removal of intrauterine device in pregnancy: a scoping review to guide personalized care. Medicina (Kaunas) 2022; 58: 1688.","journal-title":"Medicina (Kaunas)"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Liu ZL, Wang Q, Wang M, Wang B and Huang LN. Low molecular weight heparin in treating patients with lung cancer received chemotherapy: a meta-analysis. J Cancer Res Ther 2018; 14: S437-S443.","DOI":"10.4103\/0973-1482.176174"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/16\/11\/ajtr0160529.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:57:13Z","timestamp":1766023033000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/16\/11\/ajtr0160529.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":24,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.62347\/flyc9199","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]}}}